Orchard Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy ORTX

*Your capital is at risk

$16.70

+0 (+0%)

At Close: Mar 15, 2024

Currently predicting for Mon, 8 Jun 2026

ORTX Prediction Chart

ORTX Predictions History

Latest community submissions for ORTX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Feb 11, 2021	$7.93 -3.41%	$8.21	X	96.59%	0
Joey Adress @JoeyAdress.206199	Feb 11, 2021	$8.20 -0.12%	$8.21	X	99.88%	5
JS Pro	Jan 15, 2021	$6.76 -4.52%	$7.08	X	95.48%	0
JS Pro	Jan 11, 2021	$6.91 +2.83%	$6.72	X	97.17%	1

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ORTX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ORCHARD THERAPEUTICS PLC

Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's disease through a single administration. It provides Strimvelis, a gammaretroviral-based product for the...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
RUN $12.83	4.09%	May 06
GLBE $31.61	1.65%	May 05
SAP $172.39	7.18%	May 05
FIZZ $34.11	7.04%	May 01
ADBE $243.57	3.23%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by